Jessica J. Hawes - Related publications

Affiliations: 
NCI, Somers, CT, United States 
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2020 Wetendorf M, Li R, Wu SP, Liu J, Creighton CJ, Wang T, Janardhan KS, Willson CJ, Lanz RB, Murphy BD, Lydon JP, DeMayo FJ. Constitutive expression of progesterone receptor isoforms promotes the development of hormone-dependent ovarian neoplasms. Science Signaling. 13. PMID 33023986 DOI: 10.1126/scisignal.aaz9646   
2020 Xu X, Zhu Z, Xu Y, Tian S, Jiang Y, Zhao H. Effects of zinc finger protein 403 on the proliferation, migration and invasion abilities of prostate cancer cells. Oncology Reports. PMID 33125130 DOI: 10.3892/or.2020.7786   
2020 Prabhu VV, Morrow S, Rahman Kawakibi A, Zhou L, Ralff M, Ray J, Jhaveri A, Ferrarini I, Lee Y, Parker C, Zhang Y, Borsuk R, Chang WI, Honeyman JN, Tavora F, et al. ONC201 and imipridones: Anti-cancer compounds with clinical efficacy. Neoplasia (New York, N.Y.). 22: 725-744. PMID 33142238 DOI: 10.1016/j.neo.2020.09.005   
2020 Xiong Y, Zhang Y, Xiong S, Williams-Villalobo AE. A Glance of p53 Functions in Brain Development, Neural Stem Cells, and Brain Cancer. Biology. 9. PMID 32932978 DOI: 10.3390/biology9090285   
2020 Pasqualini C, Kozaki T, Bruschi M, Nguyen THH, Minard-Colin V, Castel D, Grill J, Ginhoux F. Modeling the Interaction between the Microenvironment and Tumor Cells in Brain Tumors. Neuron. PMID 33065047 DOI: 10.1016/j.neuron.2020.09.018   
2020 Ognjenovic NB, Bagheri M, Mohamed GA, Xu K, Chen Y, Mohamed Saleem MA, Brown MS, Nagaraj SH, Muller KE, Gerber SA, Christensen BC, Pattabiraman DR. Limiting Self-Renewal of the Basal Compartment by PKA Activation Induces Differentiation and Alters the Evolution of Mammary Tumors. Developmental Cell. PMID 33120014 DOI: 10.1016/j.devcel.2020.10.004   
2020 Mosa MH, Michels BE, Menche C, Nicolas AM, Darvishi T, Greten FR, Farin HF. A Wnt-induced phenotypic switch in cancer-associated fibroblasts inhibits EMT in colorectal cancer. Cancer Research. PMID 33055221 DOI: 10.1158/0008-5472.CAN-20-0263   
2020 Mao L, Yang J, Yue J, Chen Y, Zhou H, Fan D, Zhang Q, Buraschi S, Iozzo RV, Bi X. Decorin deficiency promotes epithelial-mesenchymal transition and colon cancer metastasis. Matrix Biology : Journal of the International Society For Matrix Biology. PMID 33065248 DOI: 10.1016/j.matbio.2020.10.001   
2020 Han PP, Zhang GQ, Li L, Yue L. Downregulation of USP33 inhibits Slit/Robo signaling pathway and is associated with poor patient survival of glioma. Journal of Neurosurgical Sciences. PMID 32972109 DOI: 10.23736/S0390-5616.20.04929-2   
2020 García-Heredia JM, Otero-Albiol D, Pérez M, Pérez-Castejón E, Muñoz-Galván S, Carnero A. Breast tumor cells promotes the horizontal propagation of EMT, stemness, and metastasis by transferring the MAP17 protein between subsets of neoplastic cells. Oncogenesis. 9: 96. PMID 33106480 DOI: 10.1038/s41389-020-00280-0   
2020 Ashrafizadeh M, Zarabi A, Hushmandi K, Moghadam ER, Hashemi F, Daneshi S, Hashemi F, Tavakol S, Mohammadinejad R, Najafi M, Dudha N, Garg M. C-Myc signaling pathway in treatment and prevention of brain tumors. Current Cancer Drug Targets. PMID 33069197 DOI: 10.2174/1568009620666201016121005   
2020 Murata T, Hozumi C, Hiroshima Y, Shimoya K, Hongo A, Inubushi S, Tanino H, Hoffman RM. Co-implantation of Tumor and Extensive Surrounding Tissue Improved the Establishment Rate of Surgical Specimens of Human-Patient Cancer in Nude Mice: Toward the Goal of Universal Individualized Cancer Therapy. In Vivo (Athens, Greece). 34: 3241-3245. PMID 33144429 DOI: 10.21873/invivo.12160   
2020 Raggi F, Bosco MC. Targeting Mononuclear Phagocyte Receptors in Cancer Immunotherapy: New Perspectives of the Triggering Receptor Expressed on Myeloid Cells (TREM-1). Cancers. 12. PMID 32456204 DOI: 10.3390/cancers12051337   
2020 Khalighfard S, Alizadeh AM, Poorkhani A, Motahari M, Tahmasebifar A, Omranipour R, Keshavarz P, Haddad P. Evaluation of the treatment strategies on patient-derived xenograft mice of human breast tumor. European Journal of Pharmacology. 889: 173605. PMID 32980347 DOI: 10.1016/j.ejphar.2020.173605   
2020 Reese B, Silwal A, Daugherity E, Daugherity M, Arabi M, Daly P, Paterson Y, Woolford L, Christie A, Elias R, Brugarolas J, Wang T, Karbowniczek M, Markiewski MM. Complement as Prognostic Biomarker and Potential Therapeutic Target in Renal Cell Carcinoma. Journal of Immunology (Baltimore, Md. : 1950). PMID 33158953 DOI: 10.4049/jimmunol.2000511   
2020 Hu F, Huang Y, Semtner M, Zhao K, Tan Z, Dzaye O, Kettenmann H, Shu K, Lei T. Down-regulation of Aquaporin-1 mediates a microglial phenotype switch affecting glioma growth. Experimental Cell Research. 396: 112323. PMID 33058832 DOI: 10.1016/j.yexcr.2020.112323   
2020 Samani AA, Nalbantoglu J, Brodt P. Glioma Cells With Genetically Engineered IGF-I Receptor Downregulation Can Persist in the Brain in a Dormant State. Frontiers in Oncology. 10: 555945. PMID 33072581 DOI: 10.3389/fonc.2020.555945   
2020 Zhang J. Targeting mTOR by CZ415 Suppresses Cell Proliferation and Promotes Apoptosis via Lipin-1 in Cervical Cancer In Vitro and In Vivo. Reproductive Sciences (Thousand Oaks, Calif.). PMID 32944878 DOI: 10.1007/s43032-020-00313-4   
2020 Siu L, Brody J, Gupta S, Marabelle A, Jimeno A, Munster P, Grilley-Olson J, Rook AH, Hollebecque A, Wong RKS, Welsh JW, Wu Y, Morehouse C, Hamid O, Walcott F, et al. Safety and clinical activity of intratumoral MEDI9197 alone and in combination with durvalumab and/or palliative radiation therapy in patients with advanced solid tumors. Journal For Immunotherapy of Cancer. 8. PMID 33037117 DOI: 10.1136/jitc-2020-001095   
2020 Zhang Q, Huang H, Zheng F, Liu H, Qiu F, Chen Y, Liang CL, Dai Z. Resveratrol exerts antitumor effects by downregulating CD8CD122 Tregs in murine hepatocellular carcinoma. Oncoimmunology. 9: 1829346. PMID 33150044 DOI: 10.1080/2162402X.2020.1829346   
2020 Meng B, Folaron MR, Strawbridge RR, Sadeghipour N, Samkoe KS, Tichauer K, Davis SC. Noninvasive quantification of target availability during therapy using paired-agent fluorescence tomography. Theranostics. 10: 11230-11243. PMID 33042280 DOI: 10.7150/thno.45273   
2020 Corcino De La Cena KO, Xi-Yeen Ho R, Amraei R, Woolf N, Tashjian JY, Zhao Q, Richards S, Walker J, Huang J, Chitalia V, Rahimi N. Transmembrane and immunoglobulin domain containing1 (TMIGD1), a putative tumor suppressor, induces G2-M cell cycle checkpoint arrest in colon cancer cells. The American Journal of Pathology. PMID 33129760 DOI: 10.1016/j.ajpath.2020.09.015   
2020 Zhuang X, Maione F, Robinson J, Bentley M, Kaul B, Whitworth K, Jumbu N, Jinks E, Bystrom J, Gabriele P, Garibaldi E, Delmastro E, Nagy Z, Gilham D, Giraudo E, et al. CAR T cells targeting tumor endothelial marker CLEC14A inhibit tumor growth. Jci Insight. 5. PMID 33004686 DOI: 10.1172/jci.insight.138808   
2020 Zhuang X, Maione F, Robinson J, Bentley M, Kaul B, Whitworth K, Jumbu N, Jinks E, Bystrom J, Gabriele P, Garibaldi E, Delmastro E, Nagy Z, Gilham D, Giraudo E, et al. CAR T cells targeting tumor endothelial marker CLEC14A inhibit tumor growth. Jci Insight. 5. PMID 33004686 DOI: 10.1172/jci.insight.138808   
2020 Ohkawa Y, Wade A, Lindberg OR, Chen KY, Tran VM, Brown SJ, Kumar A, Kalita M, James CD, Phillips JJ. Heparan sulfate synthesized by Ext1 regulates receptor tyrosine kinase signaling and promotes resistance to EGFR inhibitors in GBM. Molecular Cancer Research : McR. PMID 33028660 DOI: 10.1158/1541-7786.MCR-20-0420   
2020 Karagiannidis I, Jerman SJ, Jacenik D, Phinney BB, Yao R, Prossnitz ER, Beswick EJ. G-CSF and G-CSFR Modulate CD4 and CD8 T Cell Responses to Promote Colon Tumor Growth and Are Potential Therapeutic Targets. Frontiers in Immunology. 11: 1885. PMID 33042110 DOI: 10.3389/fimmu.2020.01885   
2020 Kalbasi A, Tariveranmoshabad M, Hakimi K, Kremer S, Campbell KM, Funes JM, Vega-Crespo A, Parisi G, Champekar A, Nguyen C, Torrejon D, Shin D, Zaretsky JM, Damoiseaux RD, Speiser DE, et al. Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma. Science Translational Medicine. 12. PMID 33055240 DOI: 10.1126/scitranslmed.abb0152   
2020 Corso CR, Stipp MC, Radulski DR, Mariott M, da Silva LM, de Souza Ramos EA, Klassen G, Queiroz Telles JE, Oliveira CS, Stefanello MÉA, Verhoeven AJ, Oude Elferink RPJ, Acco A. Fruticuline A, a chemically-defined diterpene, exerts antineoplastic effects in vitro and in vivo by multiple mechanisms. Scientific Reports. 10: 16477. PMID 33020521 DOI: 10.1038/s41598-020-73432-2   
2020 Zhou SZ, Li H, Wang ZW, Wang MH, Li N, Wang YF. LncRNA TSLNC8 synergizes with EGFR inhibitor osimertinib to inhibit lung cancer tumorigenesis by blocking the EGFR-STAT3 pathway. Cell Cycle (Georgetown, Tex.). 1-17. PMID 33064977 DOI: 10.1080/15384101.2020.1820697   
2020 Srijakotre N, Liu HJ, Nobis M, Man J, Yip HYK, Papa A, Abud HE, Anderson KI, Welch HCE, Tiganis T, Timpson P, McLean CA, Ooms LM, Mitchell CA. PtdIns(3,4,5)P-dependent Rac exchanger 1 (P-Rex1) promotes mammary tumor initiation and metastasis. Proceedings of the National Academy of Sciences of the United States of America. PMID 33097662 DOI: 10.1073/pnas.2006445117   
2020 Bou-Gharios J, Assi S, Bahmad HF, Kharroubi H, Araji T, Chalhoub RM, Ballout F, Harati H, Fares Y, Abou-Kheir W. The potential use of tideglusib as an adjuvant radio-therapeutic treatment for glioblastoma multiforme cancer stem-like cells. Pharmacological Reports : Pr. PMID 33140310 DOI: 10.1007/s43440-020-00180-5   
2020 Si W, Zhou B, Xie W, Li H, Li K, Li S, Deng W, Shi P, Yuan C, Ke T, Ren X, Tu X, Zeng X, Weigelt B, Rubin BP, et al. Angiogenic factor AGGF1 acts as a tumor suppressor by modulating p53 post-transcriptional modifications and stability via MDM2. Cancer Letters. PMID 33069768 DOI: 10.1016/j.canlet.2020.10.014   
2020 Jose G, Lu YJ, Hung JT, Yu AL, Chen JP. Co-Delivery of CPT-11 and Panobinostat with Anti-GD2 Antibody Conjugated Immunoliposomes for Targeted Combination Chemotherapy. Cancers. 12. PMID 33142721 DOI: 10.3390/cancers12113211   
2020 Chen YY, Lo CF, Chiu TY, Hsu CY, Yeh TK, Chen CP, Huang CL, Huang CY, Wang MH, Huang YC, Ho HH, Chao YS, Shih JC, Tsou LK, Chen CT. BPRDP056, a novel small molecule drug conjugate specifically targeting phosphatidylserine for cancer therapy. Translational Oncology. 14: 100897. PMID 33069101 DOI: 10.1016/j.tranon.2020.100897   
2020 Vickman RE, Faget DV, Beachy P, Beebe D, Bhowmick NA, Cukierman E, Deng WM, Granneman JG, Hildesheim J, Kalluri R, Lau KS, Lengyel E, Lundeberg J, Moscat J, Nelson PS, et al. Deconstructing tumor heterogeneity: the stromal perspective. Oncotarget. 11: 3621-3632. PMID 33088423 DOI: 10.18632/oncotarget.27736   
2020 Weddell J, Chiney MS, Bhatnagar S, Gibbs JP, Shebley M. Mechanistic Modeling of Intra-Tumor Spatial Distribution of Antibody-Drug Conjugates: Insights into Dosing Strategies in Oncology. Clinical and Translational Science. PMID 33073529 DOI: 10.1111/cts.12892   
2020 Buyandelger B, Bar EE, Hung KS, Chen RM, Chiang YH, Liou JP, Huang HM, Wang JY. Histone deacetylase inhibitor MPT0B291 suppresses Glioma Growth and partially through acetylation of p53. International Journal of Biological Sciences. 16: 3184-3199. PMID 33162824 DOI: 10.7150/ijbs.45505   
2020 Guey B, Bodnar-Wachtel M, Drouillard A, Eberhardt A, Pratviel M, Goutagny N, Bendriss-Vermare N, Puisieux I, Caux C, Walzer T, Petrilli V. Inflammasome Deletion Promotes Anti-tumor NK Cell Function in an IL-1/IL-18 Independent Way in Murine Invasive Breast Cancer. Frontiers in Oncology. 10: 1683. PMID 33042810 DOI: 10.3389/fonc.2020.01683   
2020 Jiang X, Wang J, Deng X, Xiong F, Zhang S, Gong Z, Li X, Cao K, Deng H, He Y, Liao Q, Xiang B, Zhou M, Guo C, Zeng Z, et al. The role of microenvironment in tumor angiogenesis. Journal of Experimental & Clinical Cancer Research : Cr. 39: 204. PMID 32993787 DOI: 10.1186/s13046-020-01709-5   
2020 Kesh K, Gupta VK, Durden B, Garrido V, Mateo-Victoriano B, Lavania SP, Banerjee S. Therapy Resistance, Cancer Stem Cells and ECM in Cancer: The Matrix Reloaded. Cancers. 12. PMID 33096662 DOI: 10.3390/cancers12103067   
2020 Lee K, Koo H, Kim Y, Kim D, Son E, Yang H, Lim Y, Hur M, Lee HW, Choi SW, Nam DH. Therapeutic Efficacy of GC1118, a Novel Anti-EGFR Antibody, against Glioblastoma with High EGFR Amplification in Patient-Derived Xenografts. Cancers. 12. PMID 33142709 DOI: 10.3390/cancers12113210   
2020 Zhong C, Jiang C, Ni S, Wang Q, Cheng L, Wang H, Zhang Q, Liu W, Zhang J, Liu J, Wang M, Jin M, Shen P, Yao X, Wang G, et al. Identification of bioactive anti-angiogenic components targeting tumor endothelial cells in Shenmai injection using multidimensional pharmacokinetics. Acta Pharmaceutica Sinica. B. 10: 1694-1708. PMID 33088689 DOI: 10.1016/j.apsb.2019.12.011   
2020 Best SA, Vandenberg CJ, Abad E, Whitehead L, Guiu L, Ding S, Brennan MS, Strasser A, Herold MJ, Sutherland KD, Janic A. Consequences of Zmat3 loss in c-MYC- and mutant KRAS-driven tumorigenesis. Cell Death & Disease. 11: 877. PMID 33082333 DOI: 10.1038/s41419-020-03066-9   
2020 Chen C, Neumann J, Kühn F, Lee SML, Drefs M, Andrassy J, Werner J, Bazhin AV, Schiergens TS. Establishment of an Endoscopy-Guided Minimally Invasive Orthotopic Mouse Model of Colorectal Cancer. Cancers. 12. PMID 33081354 DOI: 10.3390/cancers12103007   
2020 Zhang Y, Wang R, Ma F, Feng Y. The role of sialyltransferases in gynecological malignant tumors. Life Sciences. 118670. PMID 33121992 DOI: 10.1016/j.lfs.2020.118670   
2020 Lv C, Yuan D, Cao Y. . The Journal of Pharmacology and Experimental Therapeutics. PMID 33158943 DOI: 10.1124/jpet.120.000284   
2020 Colapietro A, Yang P, Rossetti A, Mancini A, Vitale F, Martellucci S, Conway TL, Chakraborty S, Marampon F, Mattei V, Gravina GL, Biordi AL, Wei D, Newman RA, Festuccia C. The Botanical Drug PBI-05204, a Supercritical CO Extract of Nerium Oleander, Inhibits Growth of Human Glioblastoma, Reduces Akt/mTOR Activities, and Modulates GSC Cell-Renewal Properties. Frontiers in Pharmacology. 11: 552428. PMID 33013390 DOI: 10.3389/fphar.2020.552428   
2020 Montay-Gruel P, Acharya MM, Gonçalves Jorge P, Petit B, Petridis IG, Fuchs P, Leavitt R, Petersson K, Gondre M, Ollivier J, Moeckli R, Bochud F, Bailat C, Bourhis J, Germond JF, et al. Hypo-fractionated FLASH-RT as an effective treatment against glioblastoma that reduces neurocognitive side effects in mice. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 33060122 DOI: 10.1158/1078-0432.CCR-20-0894   
2020 Liu D, Zhong M, Zhan D, Zhang Y, Liu S. Roles of the HGF/Met signaling in head and neck squamous cell carcinoma: Focus on tumor immunity (Review). Oncology Reports. PMID 33125120 DOI: 10.3892/or.2020.7799   
2020 Saurabh R, Nandi S, Sinha N, Shukla M, Sarkar RR. Prediction of survival rate and effect of drugs on cancer patients with somatic mutations of genes: An AI-based approach. Chemical Biology & Drug Design. 96: 1005-1019. PMID 33058465 DOI: 10.1111/cbdd.13668